BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26300030)

  • 1. Personalized Medicine and Mood Disorders.
    Alhajji L; Nemeroff CB
    Psychiatr Clin North Am; 2015 Sep; 38(3):395-403. PubMed ID: 26300030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhythm and mood: relationships between the circadian clock and mood-related behavior.
    Schnell A; Albrecht U; Sandrelli F
    Behav Neurosci; 2014 Jun; 128(3):326-43. PubMed ID: 24660658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-Guided Tailored Therapy.
    Lydiard J; Nemeroff CB
    Adv Exp Med Biol; 2019; 1192():199-224. PubMed ID: 31705496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine: Prediction of disease vulnerability in mood disorders.
    Prendes-Alvarez S; Nemeroff CB
    Neurosci Lett; 2018 Mar; 669():10-13. PubMed ID: 27746310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs.
    Le-Niculescu H; Roseberry K; Gill SS; Levey DF; Phalen PL; Mullen J; Williams A; Bhairo S; Voegtline T; Davis H; Shekhar A; Kurian SM; Niculescu AB
    Mol Psychiatry; 2021 Jul; 26(7):2776-2804. PubMed ID: 33828235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a personalized medicine for mood disorders?
    Bartova L; Berger A; Pezawas L
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S121-6. PubMed ID: 20957381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of affective and anxiety disorders.
    Leonardo ED; Hen R
    Annu Rev Psychol; 2006; 57():117-37. PubMed ID: 16318591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.
    Müller MB; Uhr M; Holsboer F; Keck ME
    Neuroendocrinology; 2004 Jan; 79(1):1-12. PubMed ID: 14755129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of circadian rhythms and mood spectrum disorders.
    Etain B; Milhiet V; Bellivier F; Leboyer M
    Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S676-82. PubMed ID: 21835597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid sensitivity in mood disorders.
    Spijker AT; van Rossum EF
    Neuroendocrinology; 2012; 95(3):179-86. PubMed ID: 22076031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is cholinergic sensitivity a genetic marker for the affective disorders?
    Janowsky DS; Overstreet DH; Nurnberger JI
    Am J Med Genet; 1994 Dec; 54(4):335-44. PubMed ID: 7726206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoepigenetics: an element of personalized therapy?
    Majchrzak-Celińska A; Baer-Dubowska W
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C; Bunck M; Glasl L; Nussbaumer M; Palme R; Stein H; Wolferstätter M; Zeh R; Zimbelmann M; Holsboer F; Landgraf R
    Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of imipramine and amitriptyline on the hypothalamic function in affective disorders.
    Horodnicki JM; Szakowski A; Wdowiak J
    Act Nerv Super (Praha); 1989 Apr; 31(1):27-9. PubMed ID: 2781995
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function in affective disorders and alcoholism.
    Loosen PT
    Neurol Clin; 1988 Feb; 6(1):55-82. PubMed ID: 3132602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders.
    Dempster EL; Burcescu I; Wigg K; Kiss E; Baji I; Gadoros J; Tamás Z; Kennedy JL; Vetró A; Kovacs M; Barr CL
    Arch Gen Psychiatry; 2007 Oct; 64(10):1189-95. PubMed ID: 17909131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment.
    Daskalakis NP; Lehrner A; Yehuda R
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):503-13. PubMed ID: 24011883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics and personalized medicine in neuropsychiatry.
    McMahon FJ; Insel TR
    Neuron; 2012 Jun; 74(5):773-6. PubMed ID: 22681682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.